AR008083A1 - Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. - Google Patents
Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc.Info
- Publication number
- AR008083A1 AR008083A1 ARP970103348A ARP970103348A AR008083A1 AR 008083 A1 AR008083 A1 AR 008083A1 AR P970103348 A ARP970103348 A AR P970103348A AR P970103348 A ARP970103348 A AR P970103348A AR 008083 A1 AR008083 A1 AR 008083A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- pharmaceutical compositions
- cns disorders
- treat cns
- prepare drugs
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se refiere a composiciones farmacéuticas en base a combinaciones de compuestos que tienen actividad antagonista de 5HT2c y de D2, compuestos quetienen actividad en los dos receptores, y su uso para la manufactura de un medicamento en eltratamiento de la esquizofrenia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615767.2A GB9615767D0 (en) | 1996-07-26 | 1996-07-26 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008083A1 true AR008083A1 (es) | 1999-12-09 |
Family
ID=10797573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103348A AR008083A1 (es) | 1996-07-26 | 1997-07-24 | Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0936924A2 (es) |
| JP (1) | JP2000516924A (es) |
| KR (1) | KR20000029564A (es) |
| CN (1) | CN1230894A (es) |
| AR (1) | AR008083A1 (es) |
| AU (1) | AU725817B2 (es) |
| BR (1) | BR9710568A (es) |
| CA (1) | CA2261813A1 (es) |
| CO (1) | CO5031292A1 (es) |
| CZ (1) | CZ23799A3 (es) |
| GB (1) | GB9615767D0 (es) |
| HU (1) | HUP9903619A3 (es) |
| IL (1) | IL128219A0 (es) |
| NO (1) | NO990322L (es) |
| NZ (1) | NZ333813A (es) |
| PL (1) | PL331426A1 (es) |
| TR (1) | TR199900140T2 (es) |
| WO (1) | WO1998004289A2 (es) |
| ZA (1) | ZA976593B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| JP2002530341A (ja) | 1998-11-23 | 2002-09-17 | セプラコール， インク． | デスメチルオランザピン組成物及び方法 |
| WO2000030648A1 (en) | 1998-11-23 | 2000-06-02 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
| AU757870B2 (en) * | 1998-11-23 | 2003-03-06 | Sepracor, Inc. | Pharmaceutical compositions containing olanzapine-N-oxide |
| EP1165090A2 (en) | 1999-03-18 | 2002-01-02 | Children's Hospital Research Foundation | A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| EP1223939A1 (en) * | 1999-05-19 | 2002-07-24 | AstraZeneca AB | Method of treating weight gain |
| WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9500998D0 (sv) * | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
-
1996
- 1996-07-26 GB GBGB9615767.2A patent/GB9615767D0/en active Pending
-
1997
- 1997-07-22 IL IL12821997A patent/IL128219A0/xx unknown
- 1997-07-22 HU HU9903619A patent/HUP9903619A3/hu unknown
- 1997-07-22 JP JP10508522A patent/JP2000516924A/ja active Pending
- 1997-07-22 CN CN97197977A patent/CN1230894A/zh active Pending
- 1997-07-22 AU AU42972/97A patent/AU725817B2/en not_active Ceased
- 1997-07-22 NZ NZ333813A patent/NZ333813A/xx unknown
- 1997-07-22 PL PL97331426A patent/PL331426A1/xx unknown
- 1997-07-22 KR KR1019997000622A patent/KR20000029564A/ko not_active Withdrawn
- 1997-07-22 CA CA002261813A patent/CA2261813A1/en not_active Abandoned
- 1997-07-22 WO PCT/EP1997/004159 patent/WO1998004289A2/en not_active Ceased
- 1997-07-22 EP EP97918947A patent/EP0936924A2/en not_active Ceased
- 1997-07-22 CZ CZ99237A patent/CZ23799A3/cs unknown
- 1997-07-22 BR BR9710568A patent/BR9710568A/pt not_active Application Discontinuation
- 1997-07-22 TR TR1999/00140T patent/TR199900140T2/xx unknown
- 1997-07-24 AR ARP970103348A patent/AR008083A1/es not_active Application Discontinuation
- 1997-07-24 ZA ZA976593A patent/ZA976593B/xx unknown
- 1997-07-25 CO CO97042582A patent/CO5031292A1/es unknown
-
1999
- 1999-01-25 NO NO990322A patent/NO990322L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000516924A (ja) | 2000-12-19 |
| CN1230894A (zh) | 1999-10-06 |
| WO1998004289A3 (en) | 1998-03-19 |
| NO990322L (no) | 1999-03-24 |
| IL128219A0 (en) | 1999-11-30 |
| KR20000029564A (ko) | 2000-05-25 |
| NZ333813A (en) | 2000-07-28 |
| CZ23799A3 (cs) | 1999-06-16 |
| CA2261813A1 (en) | 1998-02-05 |
| HUP9903619A2 (hu) | 2000-10-28 |
| TR199900140T2 (xx) | 1999-03-22 |
| CO5031292A1 (es) | 2001-04-27 |
| AU4297297A (en) | 1998-02-20 |
| ZA976593B (en) | 1999-01-25 |
| WO1998004289A2 (en) | 1998-02-05 |
| PL331426A1 (en) | 1999-07-19 |
| GB9615767D0 (en) | 1996-09-04 |
| AU725817B2 (en) | 2000-10-19 |
| NO990322D0 (no) | 1999-01-25 |
| BR9710568A (pt) | 1999-08-17 |
| EP0936924A2 (en) | 1999-08-25 |
| HUP9903619A3 (en) | 2001-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9301348A (es) | Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende. | |
| PA8435001A1 (es) | Derivados 6,6-heterobiciclicos sustituidos. | |
| CY1120313T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες | |
| ES2132105T3 (es) | 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central. | |
| AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
| ES2191192T3 (es) | Tienopirimidinas. | |
| ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
| HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
| SV1998000029A (es) | Compuestos de pirazina ref. pg3186 | |
| AR021893A1 (es) | Compuesto de 2-fenil-1-(3,4-dihidroxi-5-nitrofenil)-1-etanona sustituida , su uso para la manufactura de un medicamento en el tratamiento de algunos trastornos del sistema nervioso central y periférico y composiciones farmacéuticas que las contienen | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| AR028810A1 (es) | Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| AR025883A1 (es) | Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos | |
| AR008878A1 (es) | Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento. | |
| ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
| ES2171933T3 (es) | Derivados de androsteno. | |
| PA8457001A1 (es) | Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol | |
| ES2130152T3 (es) | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. | |
| AR008083A1 (es) | Composiciones farmaceuticas y el uso de compuestos para preparar medicamentos para tratar desordenes del snc. | |
| MX9301157A (es) | Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2052484T1 (es) | N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| NO953892D0 (no) | Imidazolokinoksalinon-derivater som EAA-antagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |